Dew, I suppose we can hope GTC is the eventual recipient of this $5.8 million for advising PharmAthene in setting up its own goat farm.
>>ANNAPOLIS, Md., March 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP ) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological terrorism, announced today that it has been awarded a contract modification providing an additional value of $5.8 million for continued development of Protexia®, the Company's broad spectrum chemical nerve agent prophylaxis.<<
Otherwise, today's GTC PR appears to be nothing but fluff.